Biosyntia, Lantana Bio in botanical deal
French white biotech firm Lantana Bio and Danish biotech Biosyntia have signed an in-licensing deal for flavonoids.
Under this, they will jointly develop production processes for flavonoids for applications mainly in food but also personal care and other applications. Biosyntia will be responsible for bringing these processes into production and commercialising the ingredients.
Flavonoids are a group of actives that are present in several traditional Chinese medicine herbs with multiple claimed health benefits. The first to be developed is kaempferol, which will be the first fermented version on the world market.
“The jointly developed technology platform will deliver today’s commercial flavonoids in a sustainable and natural way, but over time it has the potential to deliver thousands of high-quality flavonoids not previously possible to produce,” Biosyntia said.
Other News
Featured Supplier
BASF’s Personal Care business profile
BASF’s Personal Care business is the world’s leading supplier of high performance ingredients for the personal care industry. As part of BASF’s Care Chemicals division, the business provides all the resources of a global industry leader combined with consumer insights and innovation-driven...
Upcoming Events
in-cosmetics Korea 2022
Hall C, Coex, Seoul, South Korea
13 - 15 July 2022
PCHi China 2022
Shanghai World Expo Exhibition & Convention Center
18 - 20 July 2022
32nd IFSCC Congress
Park Plaza Hotel, Westminster
19-22 September 2022
in-cosmetics Latin America 2022
Expo Center Norte, Sao Paulo
21 - 22 September
Cosmetorium 2022
Palau de Congressos de Barcelona
28 - 29 September
SEPAWA 2022
Estrel Congress Center, Berlin
26 - 28 October
Access the latest issue of Personal Care Magazine on your mobile device together with an archive of back issues.
Download the FREE Personal Care Magazine app from your device's App store
